PETERS KEVIN G. 4
4 · Aerpio Pharmaceuticals, Inc. · Filed Feb 20, 2019
Insider Transaction Report
Form 4
PETERS KEVIN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-15+125,000→ 125,000 totalExercise: $3.27Exp: 2029-02-15→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]Options exercisable as to 1/4th on the first anniversary of the grant date and an additional 1/48th monthly thereafter until the fourth anniversary of the grant date.